Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $1.22 Million - $1.76 Million
10,766 New
10,766 $1.7 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $555,738 - $728,036
5,510 New
5,510 $713,000
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $680,813 - $960,458
-10,860 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $47,930 - $68,628
759 Added 7.51%
10,860 $848,000
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $780,605 - $1 Million
10,101 New
10,101 $909,000
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $1.61 Million - $2.01 Million
-23,171 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $1.45 Million - $3.39 Million
-20,044 Reduced 46.38%
23,171 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $5.43 Million - $7.72 Million
43,215 New
43,215 $7.37 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $212,970 - $393,193
-2,290 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $188,650 - $301,455
2,290 New
2,290 $224,000
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $4.97 Million - $10.7 Million
-68,203 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $7.65 Million - $10.4 Million
68,203 New
68,203 $10.4 Million
Q2 2018

Aug 10, 2018

SELL
$71.74 - $153.69 $10.4 Million - $22.2 Million
-144,500 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$54.02 - $82.27 $4.16 Million - $6.34 Million
77,100 Added 114.39%
144,500 $10.7 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $11.3 Million - $13.4 Million
-236,700 Reduced 77.84%
67,400 $3.75 Million
Q3 2017

Nov 13, 2017

BUY
$35.73 - $47.15 $10.9 Million - $14.3 Million
304,100
304,100 $13.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.